Posted Oct. 22, 2009 at 9:55 a.m.

Premium Lock Delay in H1N1 vaccine production could boost BioCryst

Published: 2009-10-22 09:55:15
Updated: 2009-10-22 09:55:15

BioCryst BioCryst

Durham-based company is developing an antiviral drug that can be delivered intraveneously....

Read More
Read More

Copyright 2017 by and the Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders